Why we are taking on skin and wounds research
Skin diseases account for a staggering 24% of the UK's burden of illness.** From common conditions like acne and eczema to severe cases such as psoriasis and skin cancer, these diseases can significantly impact patients' quality of life.
1 in 20 older people and 1 in 4 diabetics will develop a chronic wound in their lifetime. The prognosis is poor; Up to 80% of chronic wounds become infected, increasing the risk of lower limb amputation. Even more distressing, 70% of wound-related lower limb amputees die within 5 years.
Antimicrobial resistance further complicates wound care, demanding innovative solutions to replace broad-spectrum systemic antibiotics.
By focusing on this major area of unmet clinical need, we aim to revolutionise skin and wound care, improving the lives of countless patients and addressing the substantial costs associated with diagnosis, treatment, and management.
* Guest JF et al., BMJ Open. 2020 doi: 10.1136/bmjopen-2020-045253
** Global Burden of Disease project